These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 32042253

  • 1. The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan.
    Nusair MB, Al-Azzam SI, Arabyat RM, Amawi HA, Alzoubi KH, Rabah AA.
    Saudi Pharm J; 2020 Feb; 28(2):155-160. PubMed ID: 32042253
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of Potential Drug-drug Interactions With Ritonavir-containing COVID-19 Therapy in the United States: An Analysis of the National Health and Nutrition Examination Survey.
    Igho-Osagie E, Brzozowski K, Jin H, Brown J, Williams MG, Puenpatom A.
    Clin Ther; 2023 May; 45(5):390-399.e4. PubMed ID: 37032225
    [Abstract] [Full Text] [Related]

  • 3. Comparative analysis of potential drug-drug interactions in a public and private hospital among chronic kidney disease patients in Khyber Pakhtunkhwa: A retrospective cross-sectional study.
    Zafar R, Rehman IU, Shah Y, Ming LC, Goh HP, Goh KW.
    PLoS One; 2023 May; 18(9):e0291417. PubMed ID: 37773947
    [Abstract] [Full Text] [Related]

  • 4. Prevalence and Severity of Potential Drug-Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy.
    Bachmann P, Frahm N, Debus JL, Mashhadiakbar P, Langhorst SE, Streckenbach B, Baldt J, Heidler F, Hecker M, Zettl UK.
    Pharmaceutics; 2022 Mar 08; 14(3):. PubMed ID: 35335968
    [Abstract] [Full Text] [Related]

  • 5. Determination of potential drug-drug interactions in prescription orders dispensed in a community pharmacy setting using Micromedex® and Lexicomp®: a retrospective observational study.
    Abbas A, Al-Shaibi S, Sankaralingam S, Awaisu A, Kattezhathu VS, Wongwiwatthananukit S, Owusu YB.
    Int J Clin Pharm; 2022 Apr 08; 44(2):348-356. PubMed ID: 34811600
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of Drug-Related Problems in Chronic Kidney Disease Patients.
    Shouqair TM, Rabbani SA, Sridhar SB, Kurian MT.
    Cureus; 2022 Apr 08; 14(4):e24019. PubMed ID: 35573572
    [Abstract] [Full Text] [Related]

  • 7. Are patients with a nasally placed feeding tube at risk of potential drug-drug interactions? A multicentre cross-sectional study.
    Gimenes FRE, Baysari M, Walter S, Moreira LA, Carvalho REFL, Miasso AI, Faleiros F, Westbrook J.
    PLoS One; 2019 Apr 08; 14(7):e0220248. PubMed ID: 31365563
    [Abstract] [Full Text] [Related]

  • 8. Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.
    Ismail M, Iqbal Z, Khattak MB, Khan MI, Arsalan H, Javaid A, Gul Q, Khan F.
    Int J Clin Pharm; 2013 Jun 08; 35(3):455-62. PubMed ID: 23483444
    [Abstract] [Full Text] [Related]

  • 9. Potential Drug-Drug Interactions in Patients With Urinary Tract Infections: A Contributing Factor in Patient and Medication Safety.
    Noor S, Ismail M, Khan F.
    Front Pharmacol; 2019 Jun 08; 10():1032. PubMed ID: 31607905
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of Potential Drug-Drug Interaction Risk among Chronic Kidney Disease Patients in a Spanish Hospital.
    Santos-Díaz G, Pérez-Pico AM, Suárez-Santisteban MÁ, García-Bernalt V, Mayordomo R, Dorado P.
    Pharmaceutics; 2020 Jul 30; 12(8):. PubMed ID: 32751436
    [Abstract] [Full Text] [Related]

  • 11. Assessment of Potential Drug-Drug Interactions and Their Predictors in Chronic Outpatient Department of Dessie Referral Hospital, Dessie, Northeast Ethiopia.
    Gobezie MY, Bitew HB, Tuha A, Hailu HG.
    Drug Healthc Patient Saf; 2021 Jul 30; 13():29-35. PubMed ID: 33603492
    [Abstract] [Full Text] [Related]

  • 12. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.
    Secoli SR, Figueras A, Lebrão ML, de Lima FD, Santos JL.
    Drugs Aging; 2010 Sep 01; 27(9):759-70. PubMed ID: 20809665
    [Abstract] [Full Text] [Related]

  • 13. Assessment of drug interactions and their associated factors among patients with cardiovascular diseases: a cross-sectional study from the occupied Palestinian territory.
    Al-Jabi SW, Aldabe L, Alhaj-Asaad L, Thaher M, Zyoud SH, Sweileh WM.
    Lancet; 2021 Jul 01; 398 Suppl 1():S8. PubMed ID: 34227990
    [Abstract] [Full Text] [Related]

  • 14. Potential drug-drug interactions in patients with cardiovascular diseases: findings from a prospective observational study.
    Akbar Z, Rehman S, Khan A, Khan A, Atif M, Ahmad N.
    J Pharm Policy Pract; 2021 Jul 26; 14(1):63. PubMed ID: 34311787
    [Abstract] [Full Text] [Related]

  • 15. Potentially Harmful Drug-Drug Interactions and Their Associated Factors Among Hospitalized Cardiac Patients: A Cross-Sectional Study.
    Kalash A, Abdelrahman A, Al-Zakwani I, Al Suleimani Y.
    Drugs Real World Outcomes; 2023 Sep 26; 10(3):371-381. PubMed ID: 37178272
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of Polypharmacy and Potential Drug-Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study.
    Altunal LN, Yagcı Caglayık D, Ozel AS, Tukenmez Tigen E, Sili U, Erturk Sengel B, Aydın M, Korten V.
    AIDS Patient Care STDS; 2023 Mar 26; 37(3):138-145. PubMed ID: 36812461
    [Abstract] [Full Text] [Related]

  • 17. The evaluation of potential drug-drug interactions with antibiotics in hospitalized patients.
    Aydin NN, Aydin M.
    North Clin Istanb; 2024 Mar 26; 11(5):398-405. PubMed ID: 39431035
    [Abstract] [Full Text] [Related]

  • 18. Clinical decision support systems differ in their ability to identify clinically relevant drug interactions of immunosuppressants in kidney transplant patients.
    Amkreutz J, Koch A, Buendgens L, Trautwein C, Eisert A.
    J Clin Pharm Ther; 2017 Jun 26; 42(3):276-285. PubMed ID: 28224645
    [Abstract] [Full Text] [Related]

  • 19. Assessment of Clinically Relevant Drug Interactions by Online Programs in Renal Transplant Recipients.
    Tecen-Yucel K, Bayraktar-Ekincioglu A, Yildirim T, Yilmaz SR, Demirkan K, Erdem Y.
    J Manag Care Spec Pharm; 2020 Oct 26; 26(10):1291-1296. PubMed ID: 32996393
    [Abstract] [Full Text] [Related]

  • 20. Potential drug-drug interactions in patients with non-small cell lung cancer at a university hospital in Turkey.
    Albayrak A, Düzenli T, Kayıkçıoğlu E.
    J Cancer Res Clin Oncol; 2023 Sep 26; 149(12):9621-9627. PubMed ID: 37222813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.